Anish Patel, Chief Operating Officer at Enliven Therapeutics, Inc. (ELVN), sold 13,540 shares at $15.00 ($203K) on 2024-01-02, disclosed to the SEC on 2024-01-02.
Scheduled sale ($203k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.08 | 2,520 | $38K | 18.7% |
| 2 | $15.00 | 20 | $300 | 0.1% |
| 3 | $15.00 | 11,000 | $165K | 81.2% |
| Total | $15.01 avg | 13,540 | $203K | 100% |
| Filing → |
| ELVN | SELL | 2025-11-12 | $221K | — | Filing → |
| ELVN | SELL | 2025-10-09 | $268K | — | Filing → |
| ELVN | SELL | 2025-09-10 | $270K | — | Filing → |